Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02717884
Title Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) (TRANSATRA)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Michael Luebbert

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia


Cytarabine + Tranylcypromine + Tretinoin

Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.